/Companies

arcoris bio

2 known investors

Find your way into arcoris bio

Sign up to see every warm intro you have to arcoris bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the arcoris bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Arcoris Bio develops multiplex biomarker detection technology for researchers and clinicians in biomedical research and diagnostics. The company's MUSE technology enables precise, sensitive detection of multiple biomarkers across fields including cancer, immunology, neuroscience, and pharmaceutical research.

Founders & leadership

SRSimon Restrepo
Simon RestrepoSimon Restrepo is co-founder of Arcoris Bio, which develops multiplex biomarker detection technology using nanotechnology and signal amplification for biomedical research and diagnostics applications.
KBKaspar Binz
Kaspar BinzKaspar Binz is an engineer with over 20 years of experience in biologics and biotech company development. He is co-founder and CEO of Arcoris Bio, which develops multiplex biomarker detection technology for biomedical research and diagnostics.
SFScott Fraser
Scott FraserScott Fraser holds a B.S. in physics from Harvey Mudd College and a Ph.D. in biophysics from Johns Hopkins University. He has spent his career in academic research and leadership roles, including positions at UC Irvine, Caltech, and USC, with expertise in imaging, molecular analysis, and early-stage biological systems, and he now leads Arcoris Bio, which develops multiplex biomarker detection technology for biomedical research and diagnostics.

Investors · 2

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeed FundingNov 2025 · 3 sources
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does arcoris bio do?
Arcoris Bio develops multiplex biomarker detection technology for researchers and clinicians in biomedical research and diagnostics. The company's MUSE technology enables precise, sensitive detection of multiple biomarkers across fields including cancer, immunology, neuroscience, and pharmaceutical research.
Who founded arcoris bio?
arcoris bio was founded by Simon Restrepo, Kaspar Binz, Scott Fraser.
Who are arcoris bio's investors?
arcoris bio's investors include Ventura BioMed Investors, ZEISS Ventures.